Literature DB >> 33522642

Syncytia formation by SARS-CoV-2-infected cells.

Julian Buchrieser, Jérémy Dufloo, Mathieu Hubert, Blandine Monel, Delphine Planas, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Florence Guivel-Benhassine, Sylvie Van der Werf, Nicoletta Casartelli, Hugo Mouquet, Timothée Bruel, Olivier Schwartz.   

Abstract

Entities:  

Year:  2021        PMID: 33522642     DOI: 10.15252/embj.2020107405

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  18 in total

1.  Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation.

Authors:  Angela Serra; Michele Fratello; Antonio Federico; Ravi Ojha; Riccardo Provenzani; Ervin Tasnadi; Luca Cattelani; Giusy Del Giudice; Pia A S Kinaret; Laura A Saarimäki; Alisa Pavel; Suvi Kuivanen; Vincenzo Cerullo; Olli Vapalahti; Peter Horvath; Antonio Di Lieto; Jari Yli-Kauhaluoma; Giuseppe Balistreri; Dario Greco
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

2.  Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.

Authors:  Amalio Telenti; Davide Corti; Florian A Lempp; Leah B Soriaga; Martin Montiel-Ruiz; Fabio Benigni; Julia Noack; Young-Jun Park; Siro Bianchi; Alexandra C Walls; John E Bowen; Jiayi Zhou; Hannah Kaiser; Anshu Joshi; Maria Agostini; Marcel Meury; Exequiel Dellota; Stefano Jaconi; Elisabetta Cameroni; Javier Martinez-Picado; Júlia Vergara-Alert; Nuria Izquierdo-Useros; Herbert W Virgin; Antonio Lanzavecchia; David Veesler; Lisa A Purcell
Journal:  Nature       Date:  2021-08-31       Impact factor: 49.962

3.  Transmembrane domain of IFITM3 is responsible for its interaction with influenza virus HA2 subunit.

Authors:  Wang Xu; Yuhang Wang; Letian Li; Xiaoyun Qu; Quan Liu; Tiyuan Li; Shipin Wu; Ming Liao; Ningyi Jin; Shouwen Du; Chang Li
Journal:  Virol Sin       Date:  2022-07-06       Impact factor: 6.947

4.  Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry.

Authors:  Shiyou Zhu; Ying Liu; Zhuo Zhou; Zhiying Zhang; Xia Xiao; Zhiheng Liu; Ang Chen; Xiaojing Dong; Feng Tian; Shihua Chen; Yiyuan Xu; Chunhui Wang; Qiheng Li; Xuran Niu; Qian Pan; Shuo Du; Junyu Xiao; Jianwei Wang; Wensheng Wei
Journal:  Sci China Life Sci       Date:  2021-08-20       Impact factor: 10.372

5.  SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.

Authors:  Markus Hoffmann; Prerna Arora; Rüdiger Groß; Alina Seidel; Bojan F Hörnich; Alexander S Hahn; Nadine Krüger; Luise Graichen; Heike Hofmann-Winkler; Amy Kempf; Martin S Winkler; Sebastian Schulz; Hans-Martin Jäck; Bernd Jahrsdörfer; Hubert Schrezenmeier; Martin Müller; Alexander Kleger; Jan Münch; Stefan Pöhlmann
Journal:  Cell       Date:  2021-03-20       Impact factor: 41.582

6.  SARS-CoV-2 Omicron spike mediated immune escape and tropism shift.

Authors:  Ravindra Gupta
Journal:  Res Sq       Date:  2022-01-17

7.  Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients-A Target for SARS-CoV-2 Propagation.

Authors:  Veronica Ferrucci; Pasqualino de Antonellis; Fabrizio Quarantelli; Fatemeh Asadzadeh; Francesca Bibbò; Roberto Siciliano; Carmen Sorice; Ida Pisano; Barbara Izzo; Carmela Di Domenico; Angelo Boccia; Maria Vargas; Biancamaria Pierri; Maurizio Viscardi; Sergio Brandi; Giovanna Fusco; Pellegrino Cerino; Livia De Pietro; Ciro Furfaro; Leonardo Antonio Napolitano; Giovanni Paolella; Lidia Festa; Stefania Marzinotto; Maria Concetta Conte; Ivan Gentile; Giuseppe Servillo; Francesco Curcio; Tiziana de Cristofaro; Francesco Broccolo; Ettore Capoluongo; Massimo Zollo
Journal:  Int J Mol Sci       Date:  2022-02-09       Impact factor: 5.923

Review 8.  Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.

Authors:  Sébastien Boutin; Dagmar Hildebrand; Steeve Boulant; Michael Kreuter; Jule Rüter; Srinivas Reddy Pallerla; Thirumalaisamy P Velavan; Dennis Nurjadi
Journal:  Cell Mol Life Sci       Date:  2021-07-05       Impact factor: 9.261

9.  Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids.

Authors:  Waleed Rahmani; Hyunjae Chung; Sarthak Sinha; Maxwell P Bui-Marinos; Rohit Arora; Arzina Jaffer; Jennifer A Corcoran; Jeff Biernaskie; Justin Chun
Journal:  iScience       Date:  2022-01-28

10.  Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.

Authors:  Bo Meng; Adam Abdullahi; Isabella A T M Ferreira; Niluka Goonawardane; Akatsuki Saito; Izumi Kimura; Daichi Yamasoba; Pehuén Pereyra Gerber; Saman Fatihi; Surabhi Rathore; Samantha K Zepeda; Guido Papa; Steven A Kemp; Terumasa Ikeda; Mako Toyoda; Toong Seng Tan; Jin Kuramochi; Shigeki Mitsunaga; Takamasa Ueno; Kotaro Shirakawa; Akifumi Takaori-Kondo; Teresa Brevini; Donna L Mallery; Oscar J Charles; John E Bowen; Anshu Joshi; Alexandra C Walls; Laurelle Jackson; Darren Martin; Kenneth G C Smith; John Bradley; John A G Briggs; Jinwook Choi; Elo Madissoon; Kerstin B Meyer; Petra Mlcochova; Lourdes Ceron-Gutierrez; Rainer Doffinger; Sarah A Teichmann; Andrew J Fisher; Matteo S Pizzuto; Anna de Marco; Davide Corti; Myra Hosmillo; Joo Hyeon Lee; Leo C James; Lipi Thukral; David Veesler; Alex Sigal; Fotios Sampaziotis; Ian G Goodfellow; Nicholas J Matheson; Kei Sato; Ravindra K Gupta
Journal:  Nature       Date:  2022-02-01       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.